心理药物中的抗胆固醇等效:精神病学家指南
1Department of Counseling and Marital and Family Therapy, University of San Diego.
Journal of clinical psychopharmacology
|August 19, 2025
概括
一个新的抗胆固醇药物等效表有助于量化心理药物使用风险. 这种工具有助于临床医生减少抗胆固醇药物的负担,以改善患者的安全性和结果.
科学领域:
- 药理学 药理学是指药理学的学科.
- 精神病学是一个精神病学.
- 老年病的医生 老年病的医生
背景情况:
- 心理药物的抗胆固醇副作用会导致诸如认知障碍等不良事件,特别是在老年人中.
- 多种药物的累积抗胆固醇负担与不良的临床结果有关.
- 量化这种负担对于安全的处方实践至关重要.
研究的目的:
- 为精神药物制造抗胆固醇等效表 (AE) 的制定.
- 为估计各种精神药物的抗胆性负担提供一个工具.
主要方法:
- 使用二胺 (AE=1) 作为参考,创建了一个抗胆固醇等效 (AE) 表.
- 根据M1肌酸性受体与二胺相对的结合亲和关系来确定AE值.
- 还审查了药物的抗胺特性.
主要成果:
- AE表量化了许多精神药物药物的抗胆能效.
- 对某些三环抗抑郁药 (例如,阿米特利普提林) 和抗精神病药 (例如,克洛扎宾) 观察到高AE值.
- 镇静药物,如奎蒂亚平和米尔塔扎平,具有强大的抗胰岛素作用,但抗胆作用较低.
结论:
- 抗胆固醇药物等效表为精神病学家提供了一种实际的工具,以评估和比较抗胆固醇药物潜力.
- 这有助于做出明智的处方决定,以尽量减少抗胆固醇药物的负担.
- 该工具旨在提高患者的安全性和治疗结果,特别是在高风险人群中.
相关概念视频
Antipsychotic Drugs: Typical and Atypical Agents
314
Antipsychotic drugs are classified into first-generation (typical) drugs including phenothiazines; and second-generation (atypical) drugs. Chlorpromazine hydrochloride (Thorazine), a phenothiazine derivative, broadly impacts the central, autonomic, and endocrine systems. This drug, along with typical agents like haloperidol (Haldol), primarily works by antagonizing D2 receptors, thus reducing dopaminergic neurotransmission. However, typical antipsychotics can cause side effects such as sedation...
314
Cholinergic Antagonists: Pharmacokinetics
560
Cholinergic antagonists—such as antimuscarinics—are available in oral, topical, ocular, parenteral, and inhalational formulations. Most antimuscarinics are oral formulations, while scopolamine is available as a topical patch, and ipratropium and tiotropium are available as inhalation aerosols or powders. Atropine, tropicamide, and cyclopentolate are topically instilled in the eye. Most antimuscarinics are lipid-soluble and readily absorbed from the gastrointestinal tract and...
560
Indirect-Acting Cholinergic Agonists: Pharmacological Actions
828
Indirect-acting cholinergic agonists, also known as anticholinesterases, exert their pharmacological effects by enhancing cholinergic transmission in various body parts, including the neuromuscular junction, autonomic cholinergic synapses, and the brain.
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
828
Cholinergic Antagonists: Chemistry and Structure-Activity Relationship
2.4K
Cholinergic antagonists bind to cholinergic receptors and limit the effects of acetylcholine and other cholinergic agonists. Based on the specific cholinergic receptor affinity, these antagonists are classified as muscarinic or nicotinic. Anticholinergics interrupt parasympathetic innervations while sympathetic innervations remain uninterrupted. Muscarinic antagonists are also called 'muscarinic antagonists', 'antimuscarinics', or 'parasympatholytics'. Nicotinic...
2.4K
Cholinergic Antagonists: Pharmacological Actions
1.2K
Antimuscarinic drugs block muscarinic receptors in multiple systems, including the gut, eye, smooth muscles, respiratory tract, cardiovascular, and central nervous systems. They produce similar effects with varying selectivity depending on the specific agent and tissue. Here are the key pharmacological actions of antimuscarinics:
Gastrointestinal Effects: Antimuscarinics reduce gut contractions, increase gastric emptying, and slow intestinal transit. They partly inhibit gastric acid secretion...
Gastrointestinal Effects: Antimuscarinics reduce gut contractions, increase gastric emptying, and slow intestinal transit. They partly inhibit gastric acid secretion...
1.2K
Cholinergic Antagonists: Therapeutic Uses
871
Antimuscarinic drugs have various therapeutic applications by inhibiting parasympathetic stimulation in different systems. Here are the key therapeutic uses of antimuscarinics:
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...
871


